Novo Nordisk A/S (NVO) stock analysis
In our weekly check, Novo Nordisk A/S is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 7, red flags: 1.
About Novo Nordisk A/S
Novo Nordisk A/S is a Healthcare company (Drug Manufacturers - General) based in Denmark, listed on NYSE as NVO.
What our checks show for NVO
Red flags
- The stock has fallen as much as 76% from a peak. Would you have held through that?
Warning signs
- The gross margin fell by 2.4 points, to 80.8%: costs are rising faster than prices.
- Analysts expect earnings per share to shrink about 1.9% a year.
- Analysts expect only about 0.1% a year of growth in revenue.
- Analysts expect the net margin to shrink by 1.4 points from today's 33.9%.
- Free cash flow covers the dividend only 0.9 times.
- The price swings a lot: 47.3% annual volatility. Expect large ups and downs.
- The stock is still below its previous peak.
Strengths
- Operating profit covers interest 23.1 times over.
- Revenue grew 23.5% a year over the last 3 years.
- Earnings per share grew 27.7% a year over the last 3 years.
- Net profit grew 26.8% a year over the last 3 years.
- The company keeps 33.9% of its revenue as net profit.
- Free cash flow is 13.9% of revenue: cash for dividends, buybacks or growth.
Next earnings report: 2027-02-03
Similar companies
PFE · GILD · AMGN · BMY · AZN · SNY
Questions
What grade does Novo Nordisk A/S (NVO) have?
In our weekly check, Novo Nordisk A/S is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 7, red flags: 1. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of NVO stock?
This week's biggest flags for Novo Nordisk A/S: Deep past fall, Gross margin falling, Weak EPS forecast. In total 8 of 25 checks show a warning or a red flag.
What does Novo Nordisk A/S do?
Novo Nordisk A/S is a Healthcare company (Drug Manufacturers - General) based in Denmark, listed on NYSE as NVO.
When does Novo Nordisk A/S report earnings next?
The next earnings report is expected on 2027-02-03. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis